NHS

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc.

Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc. (NHS) is rated C (2.4/5) on Deltasharpe Prism, scored against Financial Services sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (D+). The rating has held at C for 11 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
B-
Factor Score 3.0 / 5.0
Growth
C-
Factor Score 1.9 / 5.0
Profitability
C+
Factor Score 2.8 / 5.0
Momentum
D+
Factor Score 1.8 / 5.0
Revisions
C+
Factor Score 2.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 9.1
EV / EBITDA N/A
Rev Growth YoY 2.9%
Gross Margin N/M
Price Return 3M -5.6%
Price Return 12M -13.4%
Catalyst Signal 0.00
Market Cap $229.4M
TTM Revenue $23.6M
Price / Sales 9.7
ROE 8.2%

Historical Factor Score Progression

Held C for 11 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B- (3.0) C- (1.9) C+ (2.8) D+ (1.8) C+ (2.5) C (2.4)
2026-11-06 B- (3.0) C- (1.9) C+ (2.8) D+ (1.8) C+ (2.5) C (2.4)
2026-10-30 B- (3.0) D+ (1.8) C+ (2.8) C- (2.0) C+ (2.5) C (2.4)
2026-10-23 B- (3.0) D+ (1.8) C+ (2.8) D+ (1.8) C+ (2.5) C (2.4)
2026-10-16 B- (3.0) D+ (1.7) C+ (2.8) D+ (1.7) C+ (2.5) C (2.3)
Page 1 of 3